# Psychiatry Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jean-Jacques Rousseau (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN003-SYN
- Date: 2026-02-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ambrose Lindqvist-Hale, MD
- Calendar frame: modern shifted

- Requested by: Celestine Marchetti-Owusu, MD

## Reason for consultation

Fixed beliefs for some nine years that former friends and colleagues are coordinating a campaign to ruin him, worse over the past year, with insomnia, in a 54-year-old writer. Please assess the diagnosis and the risk to himself and others, and advise on treatment and on his capacity to consent to urethral surgery. **S**

## History

Mr. Rousseau is seen at the request of Dr. Marchetti-Owusu. He gave a long, careful account of a campaign he believes former friends and colleagues have waged against his name for about nine years, beginning after public quarrels over his books and an attack on his previous home, and spreading in his mind to publishers, neighbors, and the staff of the house where he now lives. He believes his mail is opened and his conversations reported. He holds these beliefs with complete conviction and offers ordinary events as proof. He has never heard voices or seen things others do not, and he reports no periods of elevated mood, no sustained depression before the beliefs began, and no use of drugs. He sleeps about four hours, going over the plot at night. He works daily on his memoirs and looks after himself and his affairs. He has had no thoughts of suicide now; he recalled a passing wish to die many years ago during a painful urinary accident, without any act. He has never threatened or harmed anyone and has no wish to confront the people he fears; when afraid, his impulse is to withdraw or to move away. He agreed to the consultation for his sleep. He declined permission for collateral history. **S**

## Examination

| System | Finding |
|---|---|
| General | Tired, neatly dressed, courteous, initially guarded, warmer as the interview went on |
| Mental status | Alert and oriented; speech fluent, faster on the theme of the plot; mood "worn out"; affect anxious; thought process logical and detailed; fixed, non-bizarre persecutory beliefs held with full conviction; no hallucinations; no passivity experiences or thought interference; no suicidal or violent ideation, intent, or plan; insight into the beliefs absent; judgment intact for his own care |
| Cognition | Attention, memory, and language intact in conversation, consistent with MoCA 28 |
| Neurological | No tremor, rigidity, or abnormal movements |

BP 128/80 mmHg; pulse 80 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 63.6 kg; BMI 23.1 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Marchetti-Owusu's referral and examination; MoCA 28; PHQ-9 8 with item 9 scored 0; GAD-7 9; blood count, metabolic panel, calcium, TSH, and vitamin B12, all normal; the kidney and bladder ultrasound and the urethrogram and cystoscopy reports from five days ago, which show a 1.5 cm bulbar urethral stricture. 

## Assessment

1. **Delusional disorder, persecutory type (DSM-5-TR)** (F22). Non-bizarre persecutory delusions for well over a month (about nine years), with function preserved apart from the effects of the beliefs, and no hallucinations, disorganization, or negative symptoms, so the criteria for schizophrenia are not met. Paranoid personality disorder describes pervasive suspicious attitudes held as attitudes; his beliefs are fixed, specific, and unshaken by contrary evidence, which makes them delusions, although long-standing sensitive and suspicious traits may have preceded them. The mild depressive and anxious symptoms followed the beliefs and are not a mood episode with psychotic features. A normal neurological examination, MoCA 28, normal laboratory tests, no substance use, and a long, stable course make a medical or neurocognitive cause unlikely, so brain imaging is not needed now; it would be if cognition declined, neurological signs appeared, or the course changed. The beliefs grew from real conflicts, which should be acknowledged rather than dismissed. **S**
2. **Risk**. Low risk of suicide and of violence at present: no current ideation, no history of violence, no wish to confront anyone, no weapons, and no substance misuse. The risks to watch are sudden flight from his home, isolation, insomnia, and any shift toward wanting to confront someone. Outpatient care is safe. **S**
3. **Antipsychotic medication**. An antipsychotic often reduces the distress and preoccupation of delusional disorder, though the beliefs may persist. Aripiprazole 5 mg is the best choice for him: it has almost no anticholinergic effect, so it will not worsen urinary retention, and it causes little sedation, weight gain, or prolactin rise. Drugs with marked anticholinergic effects, such as olanzapine, quetiapine, or the low-potency first-generation drugs, should be avoided. I offered it framed around his own goals of sleep and peace of mind; he declined today, which he is entitled to do, and it should be offered again. **S**
4. **Psychological treatment and engagement**. He is suitable for cognitive behavioral therapy for psychosis aimed at distress, worry, sleep, and safety behaviors rather than at the truth of the beliefs. He accepted it. Engagement depends on not arguing with or colluding in the beliefs, acknowledging his real grievances, keeping promises, and letting him read his records. **S**
5. **Capacity and the operation**. He understands and retains information about his urinary condition and its treatment, appreciates that it applies to him, weighs the options, and communicates a choice. His beliefs do not involve his doctors or the operation. He has capacity for this decision, and the delusional disorder is not a reason to doubt it. Perioperative risk of delirium is low; avoid benzodiazepines and anticholinergic drugs, and keep his routines and written information. **S**

## Recommendations

1. Diagnosis: delusional disorder, persecutory type; no brain imaging now.
2. Cognitive behavioral therapy for psychosis, about 16 sessions with the clinic psychologist, starting next week.
3. Offer aripiprazole 5 mg each morning again at later visits; if he starts it, obtain baseline weight, waist, blood pressure, fasting glucose or hemoglobin A1c, lipids, and AIMS, and follow the monitoring schedule; avoid strongly anticholinergic antipsychotics.
4. Sleep: fixed rising time and daylight activity; no sedating antihistamines, benzodiazepines, or other anticholinergic sleep aids.
5. Review suicide and violence risk at every visit and keep the safety plan and the 988 Suicide & Crisis Lifeline current; seek urgent review if he wants to confront someone, stops sleeping, or plans to leave his home suddenly.
6. He has capacity to consent to urethral surgery; proceed with whatever he chooses after the urology discussion.
7. Give him copies of his notes and results, and keep the same clinicians where possible.

## Strengths and supports

- Supports: his long-term partner at home, his writing, and his daily walks among plants; two old correspondents he still trusts **S**

## Communication

Discussed with Dr. Marchetti-Owusu the same day. Mr. Rousseau was given a written summary of the diagnosis as "a condition that can make worries about other people fixed and exhausting" and of the options, and agreed to start the therapy. **S**

## Follow-up

Primary care continues the visits, measurement, and safety review, and may start aripiprazole whenever he chooses it without waiting for a psychiatry appointment. Psychiatry will see him again if he asks, if the risk changes, or if there is little response after twelve weeks of medication. **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Am J Psychiatry 2020;177(9):868-872 (2020), American Psychiatric Association
- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR): delusional disorder (2022), American Psychiatric Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (PHQ-9, suicide-risk review, and second-generation antipsychotic monitoring) (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
